Ipswich Investment Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
3M
MMM
|
+$3.49M |
| 2 |
ExxonMobil
XOM
|
+$2.58M |
| 3 |
AbbVie
ABBV
|
+$2.54M |
| 4 |
JPMorgan Chase
JPM
|
+$2.17M |
| 5 |
Union Pacific
UNP
|
+$2.03M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$5.53M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$4.44M |
| 3 |
Baxter International
BAX
|
+$2.46M |
| 4 |
Oracle
ORCL
|
+$1.76M |
| 5 |
Thermo Fisher Scientific
TMO
|
+$1.64M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.52% |
| 2 | Technology | 17.25% |
| 3 | Energy | 15.36% |
| 4 | Industrials | 13.57% |
| 5 | Financials | 12.63% |
Similar funds
Ipswich Investment Management's Q2 2018 Portfolio in Review
As of Q2 2018, Ipswich Investment Management held 155 positions worth $218M, down 8.2% from $237M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Ipswich Investment Management withdrew a net $26.1M in Q2 2018, closing 73 positions and reducing 29 holdings. Its most notable exit was Amazon, an estimated $5.53M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Technology and Energy.
Against the trend, Ipswich Investment Management opened a new position in Portola Pharmaceuticals, Inc. worth $1.17M.
- Ipswich Investment Management's largest Q2 2018 buy was Portola Pharmaceuticals, Inc.: 31,040 shares worth $1.17M.
- Ipswich Investment Management added most to 3M in Q2 2018, an estimated $3.49M increase.
- Ipswich Investment Management's biggest Q2 2018 reduction was Baxter International, cutting an estimated $2.46M.
- Ipswich Investment Management fully exited Amazon in Q2 2018, selling an estimated $5.53M.
- Ipswich Investment Management's ten largest holdings make up 35% of its $218M portfolio in Q2 2018.
- Ipswich Investment Management opened 4 new positions and closed 73 in Q2 2018.
- Ipswich Investment Management's portfolio value fell 8.2% quarter-over-quarter to $218M.
Based on Ipswich Investment Management's 13F filing for Q2 2018, filed 18 Jul 2018.